(24/7 MARKET NEWS) A bunch of short squeezes and small cap biotechs/pharmas are in play.
Revlon Inc. (NASDAQ: REV) continues to impress, at $4.89, up $1.16 (+31.10%), on 57,109,610 shares traded.
Clovis Oncology Inc. (NASDAQ: CLVS) is at $1.83, up $0.66 (+55.51%), on 64,686,412 shares, after hitting a high of $2.40 this morning. It’s consolidating and may make a run at today’s highs.
Mereo BioPharma Group (NASDAQ: MREO) is holding most of its recent gains, at $1.43, up $0.13 (+10%), on 23,442,236 shares, following last week’s potential AstraZeneca buyout report.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.
